Important Program For Covid Patients Closes, Leaving Many Stranded
Home Test to Treat program is closing April 16. Patients have limited options for testing and getting treatment with Paxlovid.
Source: forbes.com
📰 Radx Tech News
Radx Tech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Radx Tech. Real-time updates on events, politics, business and more.
Rapid tests play a crucial role in curbing COVID-19 infections – especially as people gather for the holidays
(The Conversation is an independent and nonprofit source of news, analysis and commentary...
United States New Hampshire Joe Biden Drug Administration Umass Chan Medical School President Joe Biden
Source: ctpost.com
Detect™ Selected by NIH to Scale Manufacturing of PCR-Quality Rapid At-Home Covid-19 Test
Detect™, Inc., a Connecticut-based health technology company, announced today that the National Institutes of Health (NIH) has selected the Detect™ Covid-19 Test to receive funding from the highly competitive Rapid Acceleration of Diagnostics Initiative (RADxSM).
United States National Institutes Of Health Rapid Acceleration Of Diagnostics Initiative Radx National Institutes Rapid Acceleration Diagnostics Initiative
Source: nih.gov
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The NIH RADx initiative announced today that it has issued contract awards totaling $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The home and point-of-care testing platforms target the need for high-performance, low-cost home tests and point-of-care tests that can potentially detect multiple respiratory infections.
Source: nih.gov
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The home and point-of-care testing platforms target the need for high-performance, low-cost home tests and point-of-care tests that can potentially detect multiple respiratory infections.
Source: nih.gov
FDA approves another at-home test
“FDA continues to authorize COVID-19 tests that will give more Americans access to greater testing flexibility and options,” FDA Commissioner Stephen M. Hahn said. “The BinaxNOW COVID-19 Ag Home Test will have a significant manufacturing footprint with the potential to support testing for millions of people.” Abbott expects to produce 30 million BinaxNOW at-home tests in the first quarter of 2021 and an additional 90 million in the second quarter. It requires a prescription, unli...
United States Stephenm Hahn Todd Merchak Drug Administration On National Institutes Of Health Washington Times
Source: washingtontimes.com
FDA approves another at-home COVID-19 test
“FDA continues to authorize COVID-19 tests that will give more Americans access to greater testing flexibility and options,” FDA Commissioner Stephen M. Hahn said. “The BinaxNOW COVID-19 Ag Home Test will have a significant manufacturing footprint with the potential to support testing for millions of people.” Abbott expects to produce 30 million BinaxNOW at-home tests in the first quarter of 2021 and an additional 90 million in the second quarter. It requires a prescription, unli...
United States Stephenm Hahn Todd Merchak Drug Administration On National Institutes Of Health Washington Times
Source: washingtontimes.com